2022 Psychiatry Update for APPs

Review state-of-the-art diagnostic and therapeutic issues and options in patients with psychiatric illness. Download slides and supporting documents of expert insights on best practices and emerging data applicable to psychiatric illness.

Share

Program Content

  • Identification and Management of Tardive Dyskinesia

    Identification and Management of Tardive Dyskinesia

    PCE On Demand Live Presentation
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 19, 2023

    Expires: January 18, 2024

    View Activity
  • An Evidence-Based Approach to Treating Major Depression

    An Evidence-Based Approach to Treating Major Depression

    PCE On Demand Live Presentation
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 19, 2023

    Expires: January 18, 2024

    View Activity
  • Treatment of Bipolar Depression and Mixed Presentations

    Treatment of Bipolar Depression and Mixed Presentations

    PCE On Demand Live Presentation
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 20, 2023

    Expires: January 19, 2024

    View Activity

Faculty

cover img faculity

Charles DeBattista, DMH, MD

Chief, Depression Research Clinic
Director, Medical Student Education in Psychiatry
Professor of Psychiatry and Behavioral Sciences
Stanford University School of Medicine
Stanford, California

cover img faculity

Amber Hoberg, PMHNP

Nurse Practitioner
MorningStar Family Medicine
Floresville, Texas

cover img faculity

Manish Jha, MD

Assistant Professor
Center for Depression Research and Clinical Care
Department of Psychiatry
UT Southwestern Medical Center
Dallas, Texas

cover img faculity

Jonathan M. Meyer, MD

Voluntary Clinical Professor, Department of Psychiatry
University of California, San Diego
Psychopharmacology Consultant
Balboa Naval Medical Center First Episode Psychosis Program
State of Nevada Project ECHO First Episode Psychosis Program

Provided by

ProCE Banner

Provided by PCE in partnership with CCO.

Supporters

Supported by educational grants from 

AbbVie

AbbVie Inc.

Intra-Cellular Therapies, Inc.

Neurocrine Biosciences, Inc.